Last 12 months
Inside the activity.
12 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 6 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 6 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 22, 2024 Filed Nov 26, 2024 21:15 UTC |
Manning Paul BDirector · 10% owner
|
PurchaseCommon Stock | 18,426,966 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-027709 · form4-11262024_041101.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,278,094 F1 · price: The reported securities are included within 18,426,966 investment units purchased by the Reporting Person for $0.89 per investment unit. Each investment unit consists of one share of Common Stock,a Series A warrant for one half of a share of common stock and a Series B warrant for one half of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series A or Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 49.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise. F2 · ownership.direct: The shares are held by Mr. Manning jointly with his spouse. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 02:02 UTC |
Rieger JaysonDirector · CEO and President
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,000,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001415889-24-026286 · form4-11072024_021140.xml · derivative · entry 1 Rieger Jayson · CIK 0002043558 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2034-11-06 F1 · derivative.exercise_date: 1/8th of the total shares subject to the option shall vest on May 5, 2025, and 1/48th of the total shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 02:04 UTC |
Kirby John J.Interim CFO
|
GrantCommon Stock | 54,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-026290 · form4-11072024_021129.xml · nonDerivative · entry 1 Kirby John J. · CIK 0001556327 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,267 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest vest in full on May 4, 2025, subject to the Reporting Person's continuous service through such date. Read SEC document |
| October 09, 2024 Filed Oct 11, 2024 16:15 UTC |
Hayes Christopher G.CHIEF LEGAL OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001415889-24-025026 · form4-10112024_041004.xml · derivative · entry 1 Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-10-09 F1 · derivative.exercise_date: 50% of the total shares subject to the option shall vest on each of April 9, 2025 and October 9, 2025, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:15 UTC |
Manning Paul BDirector · 10% owner
|
GiftCommon Stock | 891,870.42 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023835 · form4-09232024_040901.xml · nonDerivative · entry 4 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By trust Disclosed balance after: 891,870.42 F1 · kind: Upon termination of a Grantor Retained Annuity Trust, 2,675,611.25 shares were transferred to trusts for the benefit of the Reporting Person's immediate family members on September 19, 2024. F2 · ownership.nature: These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:15 UTC |
Manning Paul BDirector · 10% owner
|
GiftCommon Stock | 891,870.42 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023835 · form4-09232024_040901.xml · nonDerivative · entry 3 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By trust Disclosed balance after: 891,870.42 F1 · kind: Upon termination of a Grantor Retained Annuity Trust, 2,675,611.25 shares were transferred to trusts for the benefit of the Reporting Person's immediate family members on September 19, 2024. F2 · ownership.nature: These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:15 UTC |
Manning Paul BDirector · 10% owner
|
GiftCommon Stock | 891,870.41 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023835 · form4-09232024_040901.xml · nonDerivative · entry 2 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By trust Disclosed balance after: 891,870.41 F1 · kind: Upon termination of a Grantor Retained Annuity Trust, 2,675,611.25 shares were transferred to trusts for the benefit of the Reporting Person's immediate family members on September 19, 2024. F2 · ownership.nature: These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:15 UTC |
Manning Paul BDirector · 10% owner
|
GiftCommon Stock | 2,675,611.25 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023835 · form4-09232024_040901.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By GRAT Disclosed balance after: 0 F1 · kind: Upon termination of a Grantor Retained Annuity Trust, 2,675,611.25 shares were transferred to trusts for the benefit of the Reporting Person's immediate family members on September 19, 2024. Read SEC document |
| August 27, 2024 Filed Aug 28, 2024 20:15 UTC |
Kohler TerryCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 7,899 | $2.46 | $19,431.54 |
DisclosureSEC source: 0001415889-24-022424 · form4-08282024_040804.xml · nonDerivative · entry 2 Kohler Terry · CIK 0001872285 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,697 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.53 inclusive. Read SEC document |
| August 27, 2024 Filed Aug 28, 2024 16:15 UTC |
Hayes Christopher G.CHIEF LEGAL OFFICER
|
SaleCommon Stock | 9,530 | $2.46 | $23,443.80 |
DisclosureSEC source: 0001415889-24-022427 · form4-08282024_040809.xml · nonDerivative · entry 2 Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,773 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.53 inclusive. Read SEC document |
| August 27, 2024 Filed Aug 28, 2024 20:15 UTC |
Goldenberg GaryChief Medical Officer
|
SaleCommon Stock | 3,601 | $2.46 | $8,858.46 |
DisclosureSEC source: 0001415889-24-022426 · form4-08282024_040807.xml · nonDerivative · entry 2 Goldenberg Gary · CIK 0001741938 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,261 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.53 inclusive. Read SEC document |
| August 27, 2024 Filed Aug 28, 2024 20:15 UTC |
Bonaccorso JoeCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 8,993 | $2.46 | $22,122.78 |
DisclosureSEC source: 0001415889-24-022425 · form4-08282024_040805.xml · nonDerivative · entry 2 Bonaccorso Joe · CIK 0001741973 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,114 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.53 inclusive. Read SEC document |
| August 27, 2024 Filed Aug 28, 2024 20:15 UTC |
White TedDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 9,021 | $2.46 | $22,191.66 |
DisclosureSEC source: 0001415889-24-022423 · form4-08282024_040801.xml · nonDerivative · entry 2 White Ted · CIK 0001741964 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,967 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.53 inclusive. Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:15 UTC |
Kohler TerryCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 21,820 | $2.66 | $58,041.20 |
DisclosureSEC source: 0001415889-24-022424 · form4-08282024_040804.xml · nonDerivative · entry 1 Kohler Terry · CIK 0001872285 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,596 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 16:15 UTC |
Hayes Christopher G.CHIEF LEGAL OFFICER
|
SaleCommon Stock | 26,183 | $2.66 | $69,646.78 |
DisclosureSEC source: 0001415889-24-022427 · form4-08282024_040809.xml · nonDerivative · entry 1 Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,303 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:15 UTC |
Goldenberg GaryChief Medical Officer
|
SaleCommon Stock | 9,888 | $2.66 | $26,302.08 |
DisclosureSEC source: 0001415889-24-022426 · form4-08282024_040807.xml · nonDerivative · entry 1 Goldenberg Gary · CIK 0001741938 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,862 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:15 UTC |
Bonaccorso JoeCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 24,709 | $2.66 | $65,725.94 |
DisclosureSEC source: 0001415889-24-022425 · form4-08282024_040805.xml · nonDerivative · entry 1 Bonaccorso Joe · CIK 0001741973 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,107 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:15 UTC |
White TedDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 24,979 | $2.66 | $66,444.14 |
DisclosureSEC source: 0001415889-24-022423 · form4-08282024_040801.xml · nonDerivative · entry 1 White Ted · CIK 0001741964 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,988 F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| July 23, 2024 Filed Jul 23, 2024 18:10 UTC |
Hayes Christopher G.CHIEF LEGAL OFFICER
|
SaleCommon Stock | 91 | $6.98 | $635.18 |
DisclosureSEC source: 0001415889-24-019970 · form4-07232024_100729.xml · nonDerivative · entry 2 Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,486 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| July 23, 2024 Filed Jul 23, 2024 22:13 UTC |
White TedDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 154 | $6.98 | $1,074.92 |
DisclosureSEC source: 0001415889-24-019976 · form4-07232024_100700.xml · nonDerivative · entry 2 White Ted · CIK 0001741964 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,967 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| July 23, 2024 Filed Jul 23, 2024 22:12 UTC |
Bonaccorso JoeCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 115 | $6.98 | $802.70 |
DisclosureSEC source: 0001415889-24-019974 · form4-07232024_100716.xml · nonDerivative · entry 2 Bonaccorso Joe · CIK 0001741973 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,816 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| July 23, 2024 Filed Jul 23, 2024 22:11 UTC |
Goldenberg GaryChief Medical Officer
|
SaleCommon Stock | 86 | $6.98 | $600.28 |
DisclosureSEC source: 0001415889-24-019972 · form4-07232024_100729.xml · nonDerivative · entry 2 Goldenberg Gary · CIK 0001741938 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,750 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| July 22, 2024 Filed Jul 23, 2024 18:10 UTC |
Hayes Christopher G.CHIEF LEGAL OFFICER
|
SaleCommon Stock | 21,649 | $7.06 | $152,841.94 |
DisclosureSEC source: 0001415889-24-019970 · form4-07232024_100729.xml · nonDerivative · entry 1 Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,577 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 22, 2024 Filed Jul 23, 2024 22:13 UTC |
White TedDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 32,469 | $7.06 | $229,231.14 |
DisclosureSEC source: 0001415889-24-019976 · form4-07232024_100700.xml · nonDerivative · entry 1 White Ted · CIK 0001741964 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,121 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 22, 2024 Filed Jul 23, 2024 22:12 UTC |
Bonaccorso JoeCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 25,461 | $7.06 | $179,754.66 |
DisclosureSEC source: 0001415889-24-019974 · form4-07232024_100716.xml · nonDerivative · entry 1 Bonaccorso Joe · CIK 0001741973 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,931 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 22, 2024 Filed Jul 23, 2024 22:11 UTC |
Goldenberg GaryChief Medical Officer
|
SaleCommon Stock | 18,421 | $7.06 | $130,052.26 |
DisclosureSEC source: 0001415889-24-019972 · form4-07232024_100729.xml · nonDerivative · entry 1 Goldenberg Gary · CIK 0001741938 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,836 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:15 UTC |
Nguyen DiemDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001415889-24-015960 · form4-06072024_040611.xml · derivative · entry 1 Nguyen Diem · CIK 0001814338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-06-05 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 6, 2024 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:15 UTC |
PRYGOCKI MARK A SRDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001415889-24-015961 · form4-06072024_040613.xml · derivative · entry 1 PRYGOCKI MARK A SR · CIK 0001257544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-06-05 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 6, 2024 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:15 UTC |
Eichenfield LawrenceDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001415889-24-015959 · form4-06072024_040609.xml · derivative · entry 1 Eichenfield Lawrence · CIK 0001814892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-06-05 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 6, 2024 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:15 UTC |
Ballaron CraigDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001415889-24-015958 · form4-06072024_040607.xml · derivative · entry 1 Ballaron Craig · CIK 0001779433 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-06-05 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 6, 2024 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:31 UTC |
Kohler TerryCHIEF FINANCIAL OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001415889-24-008541 · form4-03192024_040349.xml · derivative · entry 2 Kohler Terry · CIK 0001872285 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2034-03-15 F2 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 15, 2025 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:31 UTC |
Kohler TerryCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008541 · form4-03192024_040349.xml · nonDerivative · entry 1 Kohler Terry · CIK 0001872285 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,416 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in equal annual installments on March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028 subject to the Reporting Person's continuous service through each applicable date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 16:31 UTC |
Hayes Christopher G.CHIEF LEGAL OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001415889-24-008543 · form4-03192024_040300.xml · derivative · entry 2 Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2034-03-15 F2 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 15, 2025 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 16:31 UTC |
Hayes Christopher G.CHIEF LEGAL OFFICER
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008543 · form4-03192024_040300.xml · nonDerivative · entry 1 Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,226 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in equal annual installments on March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028 subject to the Reporting Person's continuous service through each applicable date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:31 UTC |
Goldenberg GaryCHIEF MEDICAL OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001415889-24-008542 · form4-03192024_040351.xml · derivative · entry 2 Goldenberg Gary · CIK 0001741938 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2034-03-15 F2 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 15, 2025 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:31 UTC |
Goldenberg GaryCHIEF MEDICAL OFFICER
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008542 · form4-03192024_040351.xml · nonDerivative · entry 1 Goldenberg Gary · CIK 0001741938 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,257 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in equal annual installments on March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028 subject to the Reporting Person's continuous service through each applicable date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:31 UTC |
Bonaccorso JoeCHIEF COMMERCIAL OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001415889-24-008539 · form4-03192024_040347.xml · derivative · entry 2 Bonaccorso Joe · CIK 0001741973 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2034-03-15 F2 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 15, 2025 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:31 UTC |
Bonaccorso JoeCHIEF COMMERCIAL OFFICER
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008539 · form4-03192024_040347.xml · nonDerivative · entry 1 Bonaccorso Joe · CIK 0001741973 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,392 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in equal annual installments on March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028 subject to the Reporting Person's continuous service through each applicable date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:31 UTC |
White TedDirector · PRESIDENT AND CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001415889-24-008538 · form4-03192024_040342.xml · derivative · entry 2 White Ted · CIK 0001741964 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2034-03-15 F2 · derivative.exercise_date: 25% of the total shares subject to the option shall vest on March 15, 2025 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:31 UTC |
White TedDirector · PRESIDENT AND CEO
|
GrantCommon Stock | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008538 · form4-03192024_040342.xml · nonDerivative · entry 1 White Ted · CIK 0001741964 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,590 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs shall vest in equal annual installments on March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028 subject to the Reporting Person's continuous service through each applicable date. Read SEC document |
| December 29, 2023 Filed Dec 29, 2023 22:27 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 115,774 | $7.24 | $838,203.76 |
DisclosureSEC source: 0001062993-23-023292 · form4.xml · nonDerivative · entry 3 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,099,182 F3 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.02 to $7.32 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range. F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 22:27 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 126,116 | $7.08 | $892,901.28 |
DisclosureSEC source: 0001062993-23-023292 · form4.xml · nonDerivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,983,408 F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.76 to $7.30 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range. F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 22:27 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 79,726 | $7.20 | $574,027.20 |
DisclosureSEC source: 0001062993-23-023292 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,857,292 F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.90 to $7.50 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range. F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 26, 2023 Filed Dec 27, 2023 00:21 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 54,652 | $6.49 | $354,691.48 |
DisclosureSEC source: 0000899243-23-020691 · doc4.xml · nonDerivative · entry 3 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,777,566 F3 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.395 to $6.50 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range. F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 22, 2023 Filed Dec 27, 2023 00:21 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 250,000 | $6.67 | $1,667,500.00 |
DisclosureSEC source: 0000899243-23-020691 · doc4.xml · nonDerivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,722,914 F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.89 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range. F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 21, 2023 Filed Dec 27, 2023 00:21 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 200,000 | $6.17 | $1,234,000.00 |
DisclosureSEC source: 0000899243-23-020691 · doc4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,472,914 F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.00 to $6.52 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range. F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 19, 2023 Filed Dec 19, 2023 22:52 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 277,008 | $5.36 | $1,484,762.88 |
DisclosureSEC source: 0001062993-23-022861 · form4.xml · nonDerivative · entry 3 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,272,914 F3 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.065 to $5.60 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range. F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 22:52 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 456,923 | $5.41 | $2,471,953.43 |
DisclosureSEC source: 0001062993-23-022861 · form4.xml · nonDerivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,995,906 F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.06 to $6.00 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range. F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 22:52 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 500,000 | $5.97 | $2,985,000.00 |
DisclosureSEC source: 0001062993-23-022861 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,538,983 F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.3775 to $6.16 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number shares purchased at each separate price within such range. F4 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of the Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:34 UTC |
Kohler TerryChief Financial Officer
|
SaleCommon Stock | 9,632 | $2.97 | $28,607.04 |
DisclosureSEC source: 0001209191-23-055531 · doc4.xml · nonDerivative · entry 2 Kohler Terry · CIK 0001872285 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,416 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on August 24, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.95 to $3.00 inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.